Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice
- PMID: 1329314
- DOI: 10.1016/0042-6822(92)90177-q
Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice
Abstract
The nucleotide sequences of the envelope protein of the Kamiyama 1 strain of Japanese encephalitis (JE) virus and a passaged mutant (Kamiyama 2 strain) were determined. Two amino acid differences, Ser-Phe at residue 364 and Asn-Ile at residue 367, distinguished Kamiyama 2 from Kamiyama 1. Six neutralization-resistant variants were selected from these two strains using a JE species-specific monoclonal antibody with neutralization and hemagglutination-inhibition reactivities. All variants had a single amino acid substitution at residue 52 and significantly reduced reactivity with other JE species-specific monoclonal antibodies. The variants derived from Kamiyama 2 strain showed reduced virulence in 3-week-old mice after peripheral inoculation but were as virulent as the parent virus when inoculated intracranially. These variants also showed altered early virus-cell interaction but not replication and reproduction in Vero cells. These findings indicate that the mutations at residues 52, 364, and 367 affect early virus-cell interaction in Vero cells and virulence in mice.
Similar articles
-
Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants.Virology. 1991 Mar;181(1):70-7. doi: 10.1016/0042-6822(91)90471-m. Virology. 1991. PMID: 1704661
-
Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence.Virus Res. 1997 Oct;51(2):173-81. doi: 10.1016/s0168-1702(97)00098-1. Virus Res. 1997. PMID: 9498615
-
Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone.J Gen Virol. 2005 Aug;86(Pt 8):2209-2220. doi: 10.1099/vir.0.80638-0. J Gen Virol. 2005. PMID: 16033968
-
Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).J Virol. 2001 Jan;75(2):934-42. doi: 10.1128/JVI.75.2.934-942.2001. J Virol. 2001. PMID: 11134306 Free PMC article.
-
Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.Vaccine. 2010 May 7;28(21):3635-41. doi: 10.1016/j.vaccine.2010.02.105. Epub 2010 Mar 11. Vaccine. 2010. PMID: 20226891 Review.
Cited by
-
Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism.Nat Commun. 2024 Jun 19;15(1):5179. doi: 10.1038/s41467-024-49161-9. Nat Commun. 2024. PMID: 38898037 Free PMC article.
-
Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism.NPJ Vaccines. 2022 Mar 23;7(1):39. doi: 10.1038/s41541-022-00460-6. NPJ Vaccines. 2022. PMID: 35322047 Free PMC article.
-
Molecular Determinants of West Nile Virus Virulence and Pathogenesis in Vertebrate and Invertebrate Hosts.Int J Mol Sci. 2020 Nov 30;21(23):9117. doi: 10.3390/ijms21239117. Int J Mol Sci. 2020. PMID: 33266206 Free PMC article. Review.
-
Structural and molecular analyses of functional epitopes and escape mutants in Japanese encephalitis virus envelope protein domain III.Immunol Res. 2020 Apr;68(2):81-89. doi: 10.1007/s12026-020-09130-y. Immunol Res. 2020. PMID: 32445181 Free PMC article.
-
Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo.ACS Infect Dis. 2019 Mar 8;5(3):460-472. doi: 10.1021/acsinfecdis.8b00322. Epub 2019 Jan 14. ACS Infect Dis. 2019. PMID: 30608640 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases